LISTSERV - IRIS Archives - LISTSERV.ICORS.ORG

IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG

	LISTSERV Archives
	IRIS Home

	Log In
	Register

	Subscribe or Unsubscribe

	Search Archives

Options:	Use Forum View Use Monospaced Font Show Text Part by Default Show All Mail Headers
Message:	[<< First] [< Prev] [Next >] [Last >>]
Topic:	[<< First] [< Prev] [Next >] [Last >>]
Author:	[<< First] [< Prev] [Next >] [Last >>]

Subject:	news byte: approval of monthly injection for those diagnoses with schizophrenia postponed
From:	Sylvia Caras <[log in to unmask]>
Reply To:	[log in to unmask]
Date:	Mon, 1 Sep 2008 11:40:16 -0700
Content-Type:	text/plain
Parts/Attachments:	text/plain (12 lines)

 From PR Newswire - Aug 26, 2008

TITUSVILLE, N.J., August 26, 2008 /PRNewswire/ -- Johnson & Johnson 
Pharmaceutical Research & Development, L.L.C. announced today that the 
FDA has asked for additional data before it will approve the company's 
NDA for paliperidone palmitate, an investigational once-monthly atypical 
antipsychotic intramuscular injection for treating schizophrenia and 
preventing recurrence of its symptoms.


"People Who experience mood swings, fear, voices and visions"

ATOM RSS1 RSS2

LISTSERV.ICORS.ORG